However, sales of some key drugs like Prevnar, Xeljanz and Ibrance and new RSV vaccine, Abrysvo declined in the quarter. Seagen drugs contributed $915 million to the top line in the fourth quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback